- STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugsAn ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.STAT · 18d ago↗ source
- STAT+: FDA finalists under reviewThree top contenders to run the FDA are under review by the White HouseSTAT · 18d ago↗ source
- STAT+: Prime wins Beam arbitration, clearing path to clinicAstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, and more biotech news from The ReadoutSTAT · 18d ago↗ source